Efficacy of prolonged ingestion of Lactobacillus acidophilus L-92 in adult patients with atopic dermatitis

Journal of Dairy Science

Volumn 99, Issue 7, 2016, Pages 5039-5046

  Yamamoto, Kozo ^a   Yokoyama, Kazuhito ^a   Matsukawa, Takehisa ^a   Kato, Sayaka ^b   Kato, Shinji ^b   Yamada, Kazuhisa ^b   Hirota, Tatsuhiko ^b  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Asahi Soft Drinks Co Ltd   (Japan)

Author keywords

Allergy; Atopic dermatitis; Lactobacillus acidophilus; Placebo controlled double blinded parallel group comparison study

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; PROBIOTIC AGENT;

ADOLESCENT; ADULT; AGED; CHEMISTRY; DERMATITIS, ATOPIC; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; FEMALE; HUMAN; JAPAN; LACTOBACILLUS ACIDOPHILUS; MALE; MICROBIOLOGY; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOMARKERS; CYTOKINES; DERMATITIS, ATOPIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; JAPAN; LACTOBACILLUS ACIDOPHILUS; MALE; MIDDLE AGED; PROBIOTICS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84963963402     PISSN: 00220302     EISSN: 15253198     Source Type: Journal    
DOI: 10.3168/jds.2015-10605     Document Type: Article

References (27)

1. Boyle R.J., Bath-Hextall F.J., Leonardi-Bee J., Murrell D.F., Tang M.L. Probiotics for treating eczema. Cochrane Database Syst. Rev. 2008, CD006135.
2. Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., McGrady G., Wahl S.M. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 2003, 198:1875-1886.
3. Christensen H.R., Frokiaer H., Pestka J.J. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol. 2002, 168:171-178.
4. Doganci A., Eigenbrod T., Krug N., De Sanctis G.T., Hausding M., Erpenbeck V.J., Haddad el B., Lehr H.A., Schmitt E., Bopp T., Kallen K.J., Herz U., Schmitt S., Luft C., Hecht O., Hohlfeld J.M., Ito H., Nishimoto N., Yoshizaki K., Kishimoto T., Rose-John S., Renz H., Neurath M.F., Galle P.R., Finotto S. The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo. J. Clin. Invest. 2005, 115:313-325.
5. Eichenfield L.F., Lucky A.W., Boguniewicz M., Langley R.G., Cherill R., Marshall K., Bush C., Graeber M. Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents. J. Am. Acad. Dermatol. 2002, 46:495-504.
6. Harris J.M., Cullinan P., Williams H.C., Mills P., Moffat S., White C., Newman Taylor A.J. Environmental associations with eczema in early life. Br. J. Dermatol. 2001, 144:795-802.
7. Inoue Y., Kambara T., Murata N., Komori-Yamaguchi J., Matsukura S., Takahashi Y., Ikezawa Z., Aihara M. Effects of oral administration of Lactobacillus acidophilus L-92 on the symptoms and serum cytokines of atopic dermatitis in Japanese adults: A double-blind, randomized, clinical trial. Int. Arch. Allergy Immunol. 2014, 165:247-254.
8. Ishida Y., Bandou I., Kanzato H., Yamamoto N. Decrease in ovalbumin specific IgE of mice serum after oral uptake of lactic acid bacteria. Biosci. Biotechnol. Biochem. 2003, 67:951-957.
9. Ishida Y., Nakamura F., Kanzato H., Sawada D., Hirata H., Nishimura A., Kajimoto O., Fujiwara S. Clinical effects of Lactobacillus acidophilus strain L-92 on perennial allergic rhinitis: A double-blind, placebo-controlled study. J. Dairy Sci. 2005, 88:527-533. a.
10. Ishida Y., Nakamura F., Kanzato H., Sawada D., Yamamoto N., Kagata H., Oh-Ida M., Takeuchi H., Fujiwara S. Effect of milk fermented with Lactobacillus acidophilus strain L-92 on symptoms of Japanese cedar pollen allergy: A randomized placebo-controlled trial. Biosci. Biotechnol. Biochem. 2005, 69:1652-1660. b.
11. Karimi K., Inman M.D., Bienenstock J., Forsythe P. Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice. Am. J. Respir. Crit. Care Med. 2009, 179:186-193.
12. Kim S.O., Ah Y.M., Yu Y.M., Choi K.H., Shin W.G., Lee J.Y. Effects of probiotics for the treatment of atopic dermatitis: A meta-analysis of randomized controlled trials. Ann. Allergy Asthma Immunol. 2014, 113:217-226.
13. Konstantinov S.R., Smidt H., de Vos W.M., Bruijns S.C., Singh S.K., Valence F., Molle D., Lortal S., Altermann E., Klaenhammer T.R., van Kooyk Y. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc. Natl. Acad. Sci. USA 2008, 105:19474-19479.
14. Matricardi P.M., Rosmini F., Riondino S., Fortini M., Ferrigno L., Rapicetta M., Bonini S. Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: Epidemiological study. BMJ 2000, 320:412-417.
15. Mukai H., Noguchi T., Kamimura K., Nishioka K., Nishiyama S. Significance of elevated serum LDH (lactate dehydrogenase) activity in atopic dermatitis. J. Dermatol. 1990, 17:477-481.
16. Sagitani A. Anti-allergic Effects of Lactobacillus acidophilus L-92 strain. Japanese Journal of Lactic Acid Bacteria 2010, 21:207-213.
17. Schmitt J., Apfelbacher C., Spuls P.I., Thomas K.S., Simpson E.L., Furue M., Chalmers J., Williams H.C. The Harmonizing Outcome Measures for Eczema (HOME) roadmap: A methodological framework to develop core sets of outcome measurements in dermatology. J. Invest. Dermatol. 2015, 135:24-30.
18. Schmitt J., Langan S., Williams H.C. What are the best outcome measurements for atopic eczema? A systematic review. J. Allergy Clin. Immunol. 2007, 120:1389-1398.
19. Schram M.E., Spuls P.I., Leeflang M.M., Lindeboom R., Bos J.D., Schmitt J. EASI, (objective) SCORAD and POEM for atopic eczema: Responsiveness and minimal clinically important difference. Allergy 2012, 67:99-106.
20. Sistek D., Kelly R., Wickens K., Stanley T., Fitzharris P., Crane J. Is the effect of probiotics on atopic dermatitis confined to food sensitized children?. Clin. Exp. Allergy 2006, 36:629-633.
21. Smits H.H., Engering A., van der Kleij D., de Jong E.C., Schipper K., van Capel T.M., Zaat B.A., Yazdanbakhsh M., Wierenga E.A., van Kooyk Y., Kapsenberg M.L. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J. Allergy Clin. Immunol. 2005, 115:1260-1267.
22. Torii A., Torii S., Fujiwara S., Tanaka H., Inagaki N., Nagai H. Lactobacillus acidophilus strain L-92 regulates the production of Th1 cytokine as well as Th2 cytokines. Allergol. Int. 2007, 56:293-301.
23. Torii S., Torii A., Itoh K., Urisu A., Terada A., Fujisawa T., Yamada K., Suzuki H., Ishida Y., Nakamura F., Kanzato H., Sawada D., Nonaka A., Hatanaka M., Fujiwara S. Effects of oral administration of Lactobacillus acidophilus L-92 on the symptoms and serum markers of atopic dermatitis in children. Int. Arch. Allergy Immunol. 2011, 154:236-245.
24. Vliagoftis H., Kouranos V.D., Betsi G.I., Falagas M.E. Probiotics for the treatment of allergic rhinitis and asthma: Systematic review of randomized controlled trials. Ann. Allergy Asthma Immunol. 2008, 101:570-579.
25. Yazdanbakhsh M., Kremsner P.G., van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 2002, 296:490-494.
26. Yoshida T., Fujiwara W., Enomoto M., Nakayama S., Matsuda H., Sugiyama H., Shimojoh M., Okada S., Hattori M. An increased number of CD4+CD25+ cells induced by an oral administration of Lactobacillus plantarum NRIC0380 are involved in antiallergic activity. Int. Arch. Allergy Immunol. 2013, 162:283-289.
27. Zeuthen L.H., Christensen H.R., Frokiaer H. Lactic acid bacteria inducing a weak interleukin-12 and tumor necrosis factor alpha response in human dendritic cells inhibit strongly stimulating lactic acid bacteria but act synergistically with gram-negative bacteria. Clin. Vaccine Immunol. 2006, 13:365-375.